Treatment of acquired hemophilia A
Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment
Does ATP act through P2X1 receptors to regulate platelet activation and thrombus formation?
Primary and secondary agonists can use P2X1 receptors as a major pathway to increase intracellular Ca2+ in the human platelet
Platelet activation in acute pulmonary embolism
Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples
The quality of oral anticoagulant therapy and recurrent venous thrombotic events in the Leiden Thrombophilia Study
Frequency of renal impairment, advanced age, obesity and cancer in venous thromboembolism patients in clinical practice
Effects of pioglitazone on fasting and postprandial levels of lipid and hemostatic variables in overweight non-diabetic patients with coronary artery disease
Low high-density lipoprotein cholesterol predicts cardiovascular events after carotid stenting
Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation
In vivo effects of hyperthermia on the functional and conformational characteristics of antithrombin
Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia
Proteolysis of the endothelial cell protein C receptor by neutrophil proteinase 3
Loxosceles spider venom induces the release of thrombomodulin and endothelial protein C receptor
A3 domain residue Glu1829 contributes to A2 subunit retention in factor VIIIa
Comparison of local International Sensitivity Index calibration and ‘Direct INR’ methods in correction of locally reported International Normalized Ratios
Further characterization of ADAMTS-13 inactivation by thrombin
The effect of fibrinogen concentrate on thrombocytopenia
Glycoprotein VI oligomerization in cell lines and platelets
A role for glycosphingolipid-enriched microdomains in platelet glycoprotein Ib-mediated platelet activation
Effects of plasma membrane Ca2+-ATPase tyrosine phosphorylation on human platelet function
C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis
Thrombin enhances herpes simplex virus infection of cells involving protease-activated receptor 1
Phenotype of severe hemophilia A and plasma levels of risk factors for thrombosis
Atypical mutations of the prothrombin gene at positions 20 209 and 20 218, and a novel mutation at position 20 219. Report on 10 patients
A case of profound and prolonged tirofiban-induced thrombocytopenia and its correction by intravenous immunoglobulin G
Elevated total homocysteine is associated with increased platelet activation at the site of microvascular injury
Folic acid and B vitamins improve hyperhomocysteinemia-induced cardiovascular risk profile in renal transplant recipients
D-dimer as an adjunct to compression ultrasonography in patients with suspected recurrent deep vein thrombosis
Determination of pediatric norms for assessment of upper venous system post-thrombotic syndrome
Alternative diagnosis other than pulmonary embolism as a subjective variable in the Wells clinical decision rule
Simple coagulation tests improve early mortality prediction for patients in intensive care units who have proven or suspected septic shock
Caution in the interpretation of continuous thrombin generation assays
Caution in the interpretation of continuous thrombin generation assays
Evidence that pre-existent variability in platelet response to ADP accounts for ‘clopidogrel resistance’
Evidence that pre-existent variability in platelet response to ADP accounts for ‘clopidogrel resistance’